Linked from

The 10 pages that link to Immunogenicity, each with the reason it gives.

• Gene therapyRelated: Immune reactions against vectors or therapeutic proteins can limit dosing and damage treated cells.

• Stem cellRelated: Transplanted stem-cell derivatives may be rejected or attacked by the recipient's immune system.

• AntigenRelated: It separates immune stimulation from an antigen's ability to bind a receptor.

• Drug deliveryRelated: Carriers and repeated dosing can trigger immune responses that alter safety or effectiveness.

• BiosimilarRelated: Differences in immune responses can matter to biosimilar safety and effectiveness.

• Biologic therapyRelated: The body can form antibodies against a biologic, reducing its effect or causing reactions.

• Carrier proteinRelated: Carrier linkage increases the immunogenicity of many otherwise weak small molecules.

• BiopharmaceuticalRelated: A patient’s antibodies against a biopharmaceutical can reduce efficacy or cause adverse effects.

• InfliximabRelated: Antibodies against infliximab can accelerate its clearance or reduce its effectiveness.

• Therapeutic antibodyRelated: Patients can develop anti-drug antibodies that alter safety or treatment effectiveness.